Showing 7261-7270 of 7488 results for "".
- Modern Aesthetics Launches from Bryn Mawr Communicationshttps://practicaldermatology.com/news/20130228-modern_aesthetics_launches_from_bryn_mawr_communications/2459603/The debut issue of Modern Aesthetics (www.modernaesthetics.com), a publication dedicated to coverage of minimally invasive cosmetic procedures and targeting Plastic Surgeons, Facial Plastic Surgeons, Oculoplastic Surgeons, and Dermatologists, has been released by Bryn Mawr Communications III, LLC. W
- Alma Lasers to Present New Technologies at AAD Meetinghttps://practicaldermatology.com/news/20130227-alma_lasers_to_present_new_technologies_at_aad_meeting/2459604/Alma Lasers unveiled its two latest technologies, the vShape focused radiofrequency (RF) workstation and the ClearLift. The RF workstation addresses tailored anti-aging treatments for the face, body, and cellulite. The ClearLift is Q-switched technology penetrates deep beneath the skin and decreases
- Skin Cancer Treatments, Cosmetic Procedures Lead Broad Practice Scope of ASDS Membershttps://practicaldermatology.com/news/20130226-skin_cancer_treatments_cosmetic_procedures_lead_broad_practice_scope_of_asds_members/2459607/The 2012 ASDS Survey on Dermatologic Procedures found that dermatologic surgeons performed nearly 8 million medically necessary and cosmetic procedures in the United States in 2012 (a nearly 7 percent increase over 2011), showcasing their extensive training and experience.
- Brickell Biotech Announces Funding for Development of Novel Dermatology Treatmentshttps://practicaldermatology.com/news/20130226-brickell_biotech_announces_funding_for_development_of_novel_dermatology_treatments/2459608/Brickell Biotech, Inc., a development-stage pharmaceutical company focused on the development of innovative drug therapies for the treatment of skin diseases, announced a $7 million Series B financing round to fund new chemical entities in dermatology for indications including acne, atopic dermatiti
- CeraVe Launches Seven New Sunscreens with Barrier-Repairing Ceramideshttps://practicaldermatology.com/news/20130225-cerave_launches_seven_new_sunscreens_with_barrier-repairing_ceramides/2459609/Seven newCeraVe sunscreening products are now available in the Sun Protection aisle at drugstores and mass market retailers nationwide. The CeraVe Sun Care line, developed with dermatologists, includes products for the face and body with various applications offe
- Epiduo Approved For Patients as Young as 9-Years-Oldhttps://practicaldermatology.com/news/20130219-epiduo_approved_to_treat_acne_in_patients_as_young_as_nine_years_old/2459612/Based on the results of a recent clinical study in pediatric patients, the FDA has approved Epiduo (adapalene 0.1%/BPO 2.5%, Galderma) Gel to treat acne in children as young as nine years old. In the 12-week multicenter, randomized, vehicle-controlled, double-blind study, investigators evaluated the
- Mustela Unveils New Mineral Sunscreen Products for Babieshttps://practicaldermatology.com/news/20130215-mustela_unveils_new_mineral_sunscreen_products_for_babies/2459613/Mustela recently introduced a new mineral sunscreen sunscreen line for babies. The Broad Spectrum SPF 50+ Mineral Sunscreen Lotion and Broad Spectrum SPF 50+ Mineral Sunscreen Stick for baby are 100 percent mineral, with naturally derived sunscreen filters titanium dioxide and zinc oxide to ensure t
- Tri-Luma Cream Available Againhttps://practicaldermatology.com/news/20130212-tri-luma_cream_available_again/2459616/Galderma Laboratories, L.P. recently announced that Tri-Luma® (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) Cream, the only FDA-approved triple combination topical product indicated for the short-term (up to 8 weeks) treatment of moderate to severe melasma of the face, is now avai
- Survey Data Highlight Expenses and Access-to-Care for Psoriasis Patientshttps://practicaldermatology.com/news/20130208-survey_data_highlight_expenses_and_access-to-care_for_psoriasis_patients/2459618/New findings from the National Psoriasis Foundation (NPF) indicate that patients with psoriasis and psoriatic arthritis patients spend more than $2,500 per year in out-of-pocket costs for their disease. In an analysis of eight years of data to determine access-to-care issues and out-of-pocket costs
- Jan Marini Launches New Peel Systemhttps://practicaldermatology.com/news/20130206-jan_marini_launches_new_peel_system/2459619/Jan Marini Skin Research launched the Marini Peel Systems, which combine peels with concentrated retinol, peptides, and antioxidants for individuals seeking more aggressive treatments for issues ranging from sun damage to skin coloration. The systems include the Refine Peel, for skin rejuvenation, t